piperacillin has been researched along with cefotetan in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (40.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
| Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; MartÃnez-MartÃnez, L; Pomba, C | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chong, Y; Jeong, SH; Kim, MS; Lee, K; Lee, Y; Park, Y; Yong, D | 1 |
| Borgianni, L; Docquier, JD; Hanson, ND; Prandi, S; Rossolini, GM; Salden, L; Santella, G | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Marone, P; Monzillo, V; Navarra, A; Traverso, A | 1 |
| Baker, NW; Gompertz, H; Hershman, MJ; Horner, J; Logan, WA; Reilly, DT; Sackier, JM; Swift, RI; Wood, CB | 1 |
| Crokaert, F; Glupczynski, Y; Lismont, MJ; Van der Linden, MP; Yourassowsky, E | 1 |
| Landoni, F; Mangioni, C; Negri, L; Regallo, M; Scalambrino, S | 1 |
| Clausz, JC; Condon, RE; Edmiston, CE; Krepel, CJ | 1 |
| Edwards, JR; Turner, PJ | 1 |
| Mangioni, C; Quadri, G; Regallo, M; Scalambrino, S; Turtulici, P | 1 |
| Gompertz, H; Hershman, M; Reilly, D; Sackier, J; Swift, R; Wood, C | 1 |
| Consonni, R; Landoni, F; Mangioni, C; Regallo, M; Scalambrino, S | 1 |
| Brown, FV; Watt, B | 1 |
| Bassler, M; Becker, C; Daschner, FD; Just, HM | 1 |
| Alegente, G; Archetti, L; Conturso, R; de Lalla, F; Demaria, E; Doregatti, L; Pollini, F; Scalambrino, S; Tassi, PG; Zanella, GC | 1 |
| Gatti, M; Piscolla, F; Varoli, O | 1 |
| Garratty, G | 2 |
2 review(s) available for piperacillin and cefotetan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Immune hemolytic anemia caused by drugs.
Topics: Anemia, Hemolytic, Autoimmune; Cefotetan; Ceftriaxone; Coombs Test; Humans; Piperacillin | 2012 |
6 trial(s) available for piperacillin and cefotetan
| Article | Year |
|---|---|
Prospective comparative study of cefotetan with piperacillin for prophylaxis against infection in elective colorectal surgery.
Topics: Cefotetan; Colon; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperacillin; Premedication; Prospective Studies; Rectum; Surgical Wound Infection | 1990 |
Cefotetan versus piperacillin in the prophylaxis of abdominal and vaginal hysterectomy: a prospective randomized study.
Topics: Cefotetan; Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Piperacillin; Premedication; Randomized Controlled Trials as Topic; Surgical Wound Infection | 1989 |
Piperacillin in prophylaxis and therapy of gynecologic cancer patients.
Topics: Bacterial Infections; Cefotetan; Cephalosporins; Clinical Trials as Topic; Female; Humans; Hysterectomy; Ovarian Neoplasms; Piperacillin; Placebos; Postoperative Complications; Random Allocation; Uterine Neoplasms | 1987 |
A prospective comparative study of cefotetan with piperacillin for prophylaxis against infection in elective colorectal surgery.
Topics: Cefotetan; Clinical Trials as Topic; Colonic Diseases; Female; Humans; Male; Piperacillin; Prospective Studies; Random Allocation; Rectal Diseases; Sepsis; Surgical Wound Infection | 1987 |
Antibiotic prophylaxis of infection after gynecologic surgery: a prospective randomized trial between cefotetan and piperacillin.
Topics: Cefotetan; Clinical Trials as Topic; Female; Genital Neoplasms, Female; Humans; Hysterectomy; Middle Aged; Piperacillin; Postoperative Complications; Prospective Studies; Random Allocation; Surgical Wound Infection | 1987 |
Piperacillin versus cefotetan as single-dose prophylaxis in abdominal hysterectomy: a prospective, randomized, multicenter study.
Topics: Adult; Cefotetan; Female; Humans; Hysterectomy; Middle Aged; Piperacillin; Premedication; Prospective Studies; Surgical Wound Infection | 1993 |
17 other study(ies) available for piperacillin and cefotetan
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
Topics: Anti-Bacterial Agents; Cephalosporinase; Culture Media; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Models, Molecular; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Republic of Korea | 2010 |
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Meropenem; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Pseudomonas aeruginosa; Sequence Homology, Amino Acid; Thienamycins; United States | 2011 |
Antibacterial activity of combined cefotaxime and desacetyl-cefotaxime against aerobic and anaerobic gram-negative bacilli.
Topics: Bacteroides fragilis; Cefonicid; Cefotaxime; Cefotetan; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Microbial Sensitivity Tests; Piperacillin | 1990 |
Correlation between the growth and killing curves of Escherichia coli in the presence of cefotetan or piperacillin.
Topics: Cefotetan; Culture Media; Escherichia coli; Microbial Sensitivity Tests; Piperacillin; Time Factors | 1989 |
Comparative in vitro beta-lactam activity against aerobic and anaerobic surgical isolates.
Topics: Abdomen; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Cefotaxime; Cefotetan; Cefoxitin; Ceftizoxime; Cephamycins; Humans; Microbial Sensitivity Tests; Piperacillin | 1988 |
Worldwide assessment of the activity of cefotetan against clinical isolates.
Topics: Cefotetan; Cephalosporins; Clindamycin; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Information Systems; Metronidazole; Microbial Sensitivity Tests; Piperacillin | 1988 |
The comparative in-vitro activity of cefotetan against anaerobic bacteria.
Topics: Bacteria, Anaerobic; Cefotetan; Cefsulodin; Cephamycins; Drug Synergism; Microbial Sensitivity Tests; Piperacillin | 1985 |
In vitro combination effects of cefotetan with four aminoglycosides, piperacillin and mezlocillin on gram-positive and gram-negative nosocomial bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotetan; Cephamycins; Cross Infection; Drug Interactions; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mezlocillin; Microbial Sensitivity Tests; Piperacillin | 1984 |
In vitro study of the antibacterial activity of cefotetan compared with piperacillin and ceftriaxone against bacterial strains isolated from pathological material of hospital patients.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotetan; Ceftriaxone; Humans; Inpatients; Microbial Sensitivity Tests; Piperacillin | 1989 |
Drug-induced immune hemolytic anemia.
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Antineoplastic Agents; Cefotetan; Ceftriaxone; Coombs Test; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Piperacillin; Vidarabine | 2010 |